Developer docs
API playgroundTry for free, no card

Search company profiles

United Laboratories

Full company profile

uuid000dp9v

Namestring
United Laboratories
Legal namestring
United Laboratories Pvt. Ltd.
Websiteurl
unitedlabs.in
Company typeenum
Private
Founded yearint
2015
Descriptiontext

United Laboratories Pvt. Ltd. is an Indian B2B contract manufacturer of nutraceuticals, ayurvedic formulations, and derma cosmetics, founded in 2015 by Mr. Munish Goel and headquartered in Derabassi, Punjab. The company operates three WHO-GMP-certified manufacturing units — two in Derabassi and one in Birgunj, Nepal via its wholly-owned subsidiary United Laboratories Nepal Pvt. Ltd. — producing tablets, capsules, softgels, syrups, powders, injections, ointments, and gummies across 500+ SKUs covering therapeutic categories such as antidiabetic, anti-obesity, cardiology, neurology, andrology, hepatology, and gynaecology, plus health supplements (multivitamins, omega-3, collagen peptides, probiotics) and ayurvedic and derma cosmetic lines. Manufacturing is supported by in-house R&D for custom formulations, multi-jurisdiction certifications (WHO GMP, ISO 9001, ISO 22000:2018, HACCP, KOSHER, HALAL, FSSAI, DCGI, AYUSH, and FDA-compliant cosmetics), and roughly 350+ employees.

The business model is primarily contract manufacturing on a B2B basis: clients — including healthcare brands, cosmetic entrepreneurs, nutraceutical companies, and wellness businesses (1,500+ cumulative clients) — source third-party manufacturing or private-label services with flexible MOQs (e.g., 3,000-10,000 units depending on dosage form), custom formulations, and branded packaging from United Laboratories. Pricing is quote-based and varies by product complexity, volume, and packaging. Revenue is generated through manufacturing fees and export sales: the company operates direct sales offices in London (UK) and Kampala (Uganda) and exports to 13+ countries including the USA, Germany, South Africa, Nigeria, Kenya, Bangladesh, Vietnam, Sri Lanka, and the Philippines. The company's GTM motion combines third-party manufacturing channel partnerships for domestic clients with direct-to-consumer / export trade for international markets, supported by an owned website (unitedlabs.in), social media presence, trade-show participation, and SEO/content marketing.

The firm is privately held, family-operated (Founder/Managing Director Munish Goel; CEO Shubham Goel), with no disclosed institutional funding or external shareholders. It was previously known as Unibiotech Laboratories. Input data flags an important entity-disambiguation caveat: news about a United Laboratories licensing its UBT251 obesity candidate to Novo Nordisk (up to $2B in milestones) and a beta-lactamase inhibitor patent are attributed by the source material to a separately domiciled Zhuhai-based biotech entity sharing the name, not to the Indian nutraceutical contract manufacturer profiled here.

Short descriptiontext

United Laboratories is an Indian B2B third-party manufacturer producing nutraceuticals, ayurvedic formulations, and derma cosmetics across three WHO-GMP plants in Derabassi (2) and Nepal (1). It serves 1,500+ healthcare, cosmetic, and wellness brand clients across India and 13+ export markets via contract and private-label manufacturing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDera Bassi, India
HQ citystring
Dera Bassi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract manufacturing services, nutraceutical manufacturing, private label services, ayurvedic formulations, cosmetic manufacturing
Industry1 code
1Process Development & Tech Transfer Services (CDMO)
CodeHLAGABALPrimaryYes
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing32541
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Nutraceutical Contract Manufacturing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Third-Party/Contract Manufacturing
TypeProfessional Services
Description

Manufacturing services for nutraceutical and cosmetic products on behalf of other brands. The company produces products under client brands with customized formulations, packaging, and labeling. Revenue generated through production fees based on order quantity and complexity.

unitedlabs.in
2Private Label Manufacturing
TypeProfessional Services
Description

Allows brands to create their own product lines using United Laboratories' formulations and manufacturing capabilities. Clients choose ingredients, texture, fragrance, and packaging while company handles production.

unitedlabs.in
3Export Services
TypeHardware Sales
Description

International trade of manufactured nutraceutical and dietary supplement products to global markets. Company exports 500+ product range to various countries.

unitedlabs.in
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom Manufacturing Quotes
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing determined by product specifications, order volume, and packaging requirements. Minimum order quantities vary by product type (e.g., 5,000-10,000 boxes for tablets/capsules, 3,000-5,000 units for syrup).

unitedlabs.in
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

United Laboratories is a third-party contract manufacturer that produces nutraceuticals, ayurvedic formulations, and cosmetic/derma products on behalf of healthcare brands, cosmetic entrepreneurs, and wellness companies. The company offers private label services, custom formulation R&D, and produces tablets, capsules, softgels, syrups, powders, injections, and ointments in WHO-GMP certified facilities. It serves both domestic Indian clients and international markets across multiple continents through wholly-owned subsidiaries and export operations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 1500+ satisfied clients served
+3 more records
Product overview1 text field

United Laboratories is a third-party nutraceutical, cosmetic, and ayurvedic product manufacturer offering contract manufacturing and private label services. The company operates as a B2B manufacturer producing a wide portfolio of health supplements (multivitamins, omega-3, collagen peptides, probiotics), pharmaceutical formulations (antidiabetic, anti-obesity, cardiology, neurology products), skincare products (face creams, serums, face washes), haircare products, and ayurvedic preparations. Products are manufactured in WHO-GMP certified facilities in various dosage forms including tablets, capsules, softgels, syrups, powders, injections, ointments, and topical preparations. The company provides end-to-end services from formulation development through packaging and delivery.

Product and service8 records
1Nutraceuticals
CategoryNutraceuticals
Description

Dietary supplements including tablets, capsules, softgels, powders, syrups, injections, and ointments across therapeutic categories such as antidiabetic, anti-obesity, cardiology, neurology, hepatology, andrology, manufactured for healthcare and wellness brands.

2Ayurvedic Products
CategoryAyurvedic Products
Description

Herbal and Ayurvedic formulations manufactured using natural ingredients under strict quality protocols, including tablets, capsules, and other traditional preparations, for Ayurvedic medicine brands.

3Cosmetic and Derma Products
CategoryCosmetics
Description

Skincare, haircare, and personal care products including face creams, face washes, serums, lotions, oils, body washes, hair masks, and conditioners, plus derma cosmetics and ayurvedic cosmetics, manufactured for beauty brands.

4Softgel Capsules
CategoryNutraceuticals
Description

Softgel capsule formulations for nutraceutical products, providing quick absorption and extended shelf life for oils and fat-soluble vitamins, manufactured for supplement brands.

5Health Supplements
CategoryHealth Supplements
Description

Health supplements including multivitamins, amino-acid blends, antioxidants, omega-3 and cod liver oil, calcium + vitamin D3, glucosamine/chondroitin/MSM, collagen peptides, probiotics/prebiotics, and iron + folic acid + B12 formulations.

6Third-Party Manufacturing Services
CategoryContract Manufacturing
Description

Contract manufacturing services for nutraceuticals, cosmetics, and ayurvedic products including formulation, production, packaging, and delivery under WHO and GMP guidelines, offered to healthcare brands, cosmetic companies, and wellness businesses.

7Private Label Services
CategoryContract Manufacturing
Description

Private label manufacturing allowing brands to create their own beauty and wellness product lines with custom formulations, packaging design, and branding support, tailored to entrepreneurs and startup brands.

8Nutraceutical Export Services
CategoryExport Services
Description

International export services for manufactured nutraceutical and dietary supplement products to global markets including USA, Europe, South Africa, Nigeria, Uganda, Kenya, Bangladesh, Vietnam, Sri Lanka, and Philippines, operated through foreign agencies and wholly-owned overseas offices.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-03-01
Description

Licensing agreement where Novo Nordisk acquired global rights to UBT251, a triple GLP-1/GIP/glucagon agonist obesity drug developed jointly by United Laboratories (through its subsidiary United Biotechnology). Novo Nordisk paid $200 million upfront with potential milestones up to $2 billion. United Laboratories conducted phase 2 trials in China showing 19.7% weight loss after 24 weeks. Global trial results expected in 2027.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Zenova Bio Nutrition
TypeDirect peer
Description

India-based contract manufacturer specializing in nutraceuticals and dietary supplements with private label and third-party manufacturing services. Closely comparable business model and customer segment to United Labs.

TypeRegional player
Description

India-based pharmaceutical contract manufacturer producing solid oral, semi-solid, and liquid dosage forms primarily for regulated export markets. Comparable CDMO model, though Medreich's customer base is more skewed to large European generic pharma companies.

TypeBroad incumbent
Description

Larger India-based contract development and manufacturing organization serving global pharma and biotech customers. Comparable in CDMO positioning, though more focused on API and clinical-stage development than nutraceuticals.

TypeDirect peer
Description

Indian CDMO focused on solid and liquid oral dosage forms for global pharmaceutical and nutraceutical companies. Comparable as a contract manufacturer with GMP certifications and export footprint serving similar B2B customers.

TypeDirect peer
Description

One of India's largest contract manufacturers of pharmaceuticals, nutraceuticals, and cosmetics with multi-format dosage capabilities and GMP-certified facilities. Highly comparable to United Labs as a domestic CDMO serving brand customers across India and international markets.

TypeBroad incumbent
Description

Major Ayurvedic and herbal products company with in-house manufacturing and a broad domestic and international footprint. Comparable through Ayurvedic formulation expertise and GMP manufacturing, though primarily brand-led rather than contract manufacturing.

TypeDirect peer
Description

Indian pharmaceutical contract manufacturer producing tablets, capsules, softgels, syrups, and ointments for domestic and export markets. Directly comparable in dosage-form breadth and third-party manufacturing model.

TypeEmerging player
Description

US-based contract manufacturer and packager of supplements, nutraceuticals, and over-the-counter products serving private-label customers. Comparable in B2B third-party manufacturing and private-label services for nutraceutical brands.

TypeBroad incumbent
Description

Large Indian FMCG and Ayurvedic products company with extensive in-house manufacturing of nutraceuticals, cosmetics, and Ayurvedic preparations. Comparable through Ayurvedic manufacturing scale and product breadth, though it is primarily a brand owner rather than a CDMO.

TypeEmerging player
Description

US-based contract manufacturer of softgel capsules and nutritional supplements. Comparable as a private-label and contract nutraceutical manufacturer, though geographically focused on the US market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

United Laboratories

Nutraceutical Contract Manufacturingunitedlabs.in

United Laboratories is an Indian B2B third-party manufacturer producing nutraceuticals, ayurvedic formulations, and derma cosmetics across three WHO-GMP plants in Derabassi (2) and Nepal (1). It serves 1,500+ healthcare, cosmetic, and wellness brand clients across India and 13+ export markets via contract and private-label manufacturing.

What United Laboratories does

United Laboratories Pvt. Ltd. is an Indian B2B contract manufacturer of nutraceuticals, ayurvedic formulations, and derma cosmetics, founded in 2015 by Mr. Munish Goel and headquartered in Derabassi, Punjab. The company operates three WHO-GMP-certified manufacturing units — two in Derabassi and one in Birgunj, Nepal via its wholly-owned subsidiary United Laboratories Nepal Pvt. Ltd. — producing tablets, capsules, softgels, syrups, powders, injections, ointments, and gummies across 500+ SKUs covering therapeutic categories such as antidiabetic, anti-obesity, cardiology, neurology, andrology, hepatology, and gynaecology, plus health supplements (multivitamins, omega-3, collagen peptides, probiotics) and ayurvedic and derma cosmetic lines. Manufacturing is supported by in-house R&D for custom formulations, multi-jurisdiction certifications (WHO GMP, ISO 9001, ISO 22000:2018, HACCP, KOSHER, HALAL, FSSAI, DCGI, AYUSH, and FDA-compliant cosmetics), and roughly 350+ employees.

The business model is primarily contract manufacturing on a B2B basis: clients — including healthcare brands, cosmetic entrepreneurs, nutraceutical companies, and wellness businesses (1,500+ cumulative clients) — source third-party manufacturing or private-label services with flexible MOQs (e.g., 3,000-10,000 units depending on dosage form), custom formulations, and branded packaging from United Laboratories. Pricing is quote-based and varies by product complexity, volume, and packaging. Revenue is generated through manufacturing fees and export sales: the company operates direct sales offices in London (UK) and Kampala (Uganda) and exports to 13+ countries including the USA, Germany, South Africa, Nigeria, Kenya, Bangladesh, Vietnam, Sri Lanka, and the Philippines. The company's GTM motion combines third-party manufacturing channel partnerships for domestic clients with direct-to-consumer / export trade for international markets, supported by an owned website (unitedlabs.in), social media presence, trade-show participation, and SEO/content marketing.

The firm is privately held, family-operated (Founder/Managing Director Munish Goel; CEO Shubham Goel), with no disclosed institutional funding or external shareholders. It was previously known as Unibiotech Laboratories. Input data flags an important entity-disambiguation caveat: news about a United Laboratories licensing its UBT251 obesity candidate to Novo Nordisk (up to $2B in milestones) and a beta-lactamase inhibitor patent are attributed by the source material to a separately domiciled Zhuhai-based biotech entity sharing the name, not to the Indian nutraceutical contract manufacturer profiled here.

United Laboratories firmographics

Firmographics
Name
United Laboratories
Legal name
United Laboratories Pvt. Ltd.
Website
https://unitedlabs.in
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
United Laboratories is an Indian B2B third-party manufacturer producing nutraceuticals, ayurvedic formulations, and derma cosmetics across three WHO-GMP plants in Derabassi (2) and Nepal (1). It serves 1,500+ healthcare, cosmetic, and wellness brand clients across India and 13+ export markets via contract and private-label manufacturing.
Ownership category
akta.pro rank

United Laboratories industry classification

Industry
Product category
Nutraceutical Contract Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834)
akta.pro primary industry
Process Development & Tech Transfer Services (CDMO) (HLAGABAL)

Keywords

  • Contract manufacturing services
  • Nutraceutical manufacturing
  • Private label services
  • Ayurvedic formulations
  • Cosmetic manufacturing

Where United Laboratories is headquartered

Location

Headquarters

HQ city
Dera Bassi
HQ country
India
HQ region
Asia

Offices6 records

Markets served

United Laboratories business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Third-Party/Contract Manufacturing: Manufacturing services for nutraceutical and cosmetic products on behalf of other brands. The company produces products under client brands with customized formulations, packaging, and labeling. Revenue generated through production fees based on order quantity and complexity.
  2. Private Label Manufacturing: Allows brands to create their own product lines using United Laboratories' formulations and manufacturing capabilities. Clients choose ingredients, texture, fragrance, and packaging while company handles production.
  3. Export Services: International trade of manufactured nutraceutical and dietary supplement products to global markets. Company exports 500+ product range to various countries.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom Manufacturing Quotes

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

United Laboratories product offering

Product offering

Core offering

United Laboratories is a third-party contract manufacturer that produces nutraceuticals, ayurvedic formulations, and cosmetic/derma products on behalf of healthcare brands, cosmetic entrepreneurs, and wellness companies. The company offers private label services, custom formulation R&D, and produces tablets, capsules, softgels, syrups, powders, injections, and ointments in WHO-GMP certified facilities. It serves both domestic Indian clients and international markets across multiple continents through wholly-owned subsidiaries and export operations.

Product overview

United Laboratories is a third-party nutraceutical, cosmetic, and ayurvedic product manufacturer offering contract manufacturing and private label services. The company operates as a B2B manufacturer producing a wide portfolio of health supplements (multivitamins, omega-3, collagen peptides, probiotics), pharmaceutical formulations (antidiabetic, anti-obesity, cardiology, neurology products), skincare products (face creams, serums, face washes), haircare products, and ayurvedic preparations. Products are manufactured in WHO-GMP certified facilities in various dosage forms including tablets, capsules, softgels, syrups, powders, injections, ointments, and topical preparations. The company provides end-to-end services from formulation development through packaging and delivery.

Differentiator

Problem solved

Functional benefit

Products and services

  • Nutraceuticals Dietary supplements including tablets, capsules, softgels, powders, syrups, injections, and ointments across therapeutic categories such as antidiabetic, anti-obesity, cardiology, neurology, hepatology, andrology, manufactured for healthcare and wellness brands.
  • Ayurvedic Products Herbal and Ayurvedic formulations manufactured using natural ingredients under strict quality protocols, including tablets, capsules, and other traditional preparations, for Ayurvedic medicine brands.
  • Cosmetic and Derma Products Skincare, haircare, and personal care products including face creams, face washes, serums, lotions, oils, body washes, hair masks, and conditioners, plus derma cosmetics and ayurvedic cosmetics, manufactured for beauty brands.
  • Softgel Capsules Softgel capsule formulations for nutraceutical products, providing quick absorption and extended shelf life for oils and fat-soluble vitamins, manufactured for supplement brands.
  • Health Supplements Health supplements including multivitamins, amino-acid blends, antioxidants, omega-3 and cod liver oil, calcium + vitamin D3, glucosamine/chondroitin/MSM, collagen peptides, probiotics/prebiotics, and iron + folic acid + B12 formulations.
  • Third-Party Manufacturing Services Contract manufacturing services for nutraceuticals, cosmetics, and ayurvedic products including formulation, production, packaging, and delivery under WHO and GMP guidelines, offered to healthcare brands, cosmetic companies, and wellness businesses.
  • Private Label Services Private label manufacturing allowing brands to create their own beauty and wellness product lines with custom formulations, packaging design, and branding support, tailored to entrepreneurs and startup brands.
  • Nutraceutical Export Services International export services for manufactured nutraceutical and dietary supplement products to global markets including USA, Europe, South Africa, Nigeria, Uganda, Kenya, Bangladesh, Vietnam, Sri Lanka, and Philippines, operated through foreign agencies and wholly-owned overseas offices.

Quantifiable outcome

  • 1500+ satisfied clients served
  • +3 more outcomes

Companies that use United Laboratories

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

United Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

United Laboratories partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Novo NordiskflagshipStrategic or Co-development Partner · 1 March 2025Licensing agreement where Novo Nordisk acquired global rights to UBT251, a triple GLP-1/GIP/glucagon agonist obesity drug developed jointly by United Laboratories (through its subsidiary United Biotechnology). Novo Nordisk paid $200 million upfront with potential milestones up to $2 billion. United Laboratories conducted phase 2 trials in China showing 19.7% weight loss after 24 weeks. Global trial results expected in 2027.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

United Laboratories competitors and assessment

Company assessment

Direct peers

  • Zenova Bio Nutrition: India-based contract manufacturer specializing in nutraceuticals and dietary supplements with private label and third-party manufacturing services. Closely comparable business model and customer segment to United Labs.
  • Windlas Biotech: Indian CDMO focused on solid and liquid oral dosage forms for global pharmaceutical and nutraceutical companies. Comparable as a contract manufacturer with GMP certifications and export footprint serving similar B2B customers.
  • Akums Drugs & Pharmaceuticals: One of India's largest contract manufacturers of pharmaceuticals, nutraceuticals, and cosmetics with multi-format dosage capabilities and GMP-certified facilities. Highly comparable to United Labs as a domestic CDMO serving brand customers across India and international markets.
  • Tirupati Group (formerly Medicamen Biotech): Indian pharmaceutical contract manufacturer producing tablets, capsules, softgels, syrups, and ointments for domestic and export markets. Directly comparable in dosage-form breadth and third-party manufacturing model.

Regional players

  • Medreich (Advent International portfolio): India-based pharmaceutical contract manufacturer producing solid oral, semi-solid, and liquid dosage forms primarily for regulated export markets. Comparable CDMO model, though Medreich's customer base is more skewed to large European generic pharma companies.

Broad incumbents

  • Sai Life Sciences: Larger India-based contract development and manufacturing organization serving global pharma and biotech customers. Comparable in CDMO positioning, though more focused on API and clinical-stage development than nutraceuticals.
  • Himalaya Wellness: Major Ayurvedic and herbal products company with in-house manufacturing and a broad domestic and international footprint. Comparable through Ayurvedic formulation expertise and GMP manufacturing, though primarily brand-led rather than contract manufacturing.
  • Patanjali Ayurved: Large Indian FMCG and Ayurvedic products company with extensive in-house manufacturing of nutraceuticals, cosmetics, and Ayurvedic preparations. Comparable through Ayurvedic manufacturing scale and product breadth, though it is primarily a brand owner rather than a CDMO.

Emerging players

  • Makers Nutrition: US-based contract manufacturer and packager of supplements, nutraceuticals, and over-the-counter products serving private-label customers. Comparable in B2B third-party manufacturing and private-label services for nutraceutical brands.
  • Robinson Pharma: US-based contract manufacturer of softgel capsules and nutritional supplements. Comparable as a private-label and contract nutraceutical manufacturer, though geographically focused on the US market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

United Laboratories social profiles

Digital presence

United Laboratories compliance and trust

Trust signal

Compliance8 records

United Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

United Laboratories leadership team

Management profile

Number of profiles

Profiles2 records

United Laboratories subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

United Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

United Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about United Laboratories

What does United Laboratories do?

United Laboratories is a third-party contract manufacturer that produces nutraceuticals, ayurvedic formulations, and cosmetic/derma products on behalf of healthcare brands, cosmetic entrepreneurs, and wellness companies. The company offers private label services, custom formulation R&D, and produces tablets, capsules, softgels, syrups, powders, injections, and ointments in WHO-GMP certified facilities. It serves both domestic Indian clients and international markets across multiple continents through wholly-owned subsidiaries and export operations.

Is United Laboratories a public or private company?

United Laboratories is a private company. It is classified as family owned and is currently operating.

When was United Laboratories founded?

United Laboratories was founded in 2015. It employs 11 to 50 people.

Where is United Laboratories based?

United Laboratories is headquartered in Dera Bassi, India, in the Asia region.

How does United Laboratories make money?

Three revenue lines are on record. Third-Party/Contract Manufacturing is the primary driver. The others are private Label Manufacturing and export Services.

Who are United Laboratories's main competitors?

Direct peers on record are Zenova Bio Nutrition, Windlas Biotech, Akums Drugs & Pharmaceuticals and Tirupati Group (formerly Medicamen Biotech). Medreich (Advent International portfolio) is listed as a regional player. Broad incumbents are Sai Life Sciences, Himalaya Wellness and Patanjali Ayurved. Emerging players are Makers Nutrition and Robinson Pharma.

Does United Laboratories have an API?

No public API is recorded for United Laboratories.

What industry is United Laboratories in?

United Laboratories's product category is Nutraceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAL, Process Development & Tech Transfer Services (CDMO). Its NAICS code is 32541 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AInvestMedicare's $50 GLP-1 Deal Just Rescued Lilly's Setup in a Market Still Worth $73B by 2034Medicare has finalized a $50-per-month cap on GLP-1 obesity treatments for beneficiaries through a bridge period running from July 1 through December 31, 2027, a policy shift that expands access for nearly 40 million Americans on government insurance programs into a market projected to reach $73 billion by 2034 in the US alone. Eli Lilly's Medicare agreement explicitly covers Zepbound and orforglipron, positioning the company to capture additional demand through lower out-of-pocket friction, while rival Novo Nordisk currently leads in execution with Wegovy pill prescriptions topping 3 million and has reinforced its pipeline by licensing a triple agonist from United Laboratories worth up to $1.8 billion in milestones. The article frames the real test as whether the temporary bridge produces durable adoption signals or merely a short-term affordability spike, with both companies preparing for intensified competition in the obesity drug space.The Pharma LetterNovo Nordisk, TUL advance triple agonist after Phase II dataNovo Nordisk and TUL reported Phase II data for UBT251, a triple agonist, in Chinese patients with type 2 diabetes. The drug showed a peak HbA1c reduction of 2.16% after 24 weeks, versus 1.77% for semaglutide and 0.66% for placebo, with weight loss up to 9.8%, roughly double that of semaglutide.Longevity.TechnologyNovo’s triple-G obesity drug hits 19.7% loss in China trialNovo Nordisk and United Laboratories reported that their jointly developed triple-agonist obesity drug UBT251 achieved 19.7% average weight loss after 24 weeks in a phase 2 trial involving 205 participants in China, compared to approximately 2% for placebo, with additional improvements in waist circumference, blood glucose, blood pressure and blood lipids. The drug works on three hormonal pathways simultaneously and demonstrated a tolerability profile consistent with other incretin-based therapies, though the trial lasted only 24 weeks and long-term data remains pending. Novo has initiated a global trial of UBT251 with approximately 330 participants and expects results in 2027, with plans to begin testing in type 2 diabetes patients in 2026.ReutersNovo Nordisk, United Laboratories 'triple G' drug trial shows 19.7% weight lossNovo Nordisk and United Laboratories reported phase 2 trial results showing their obesity drug candidate UBT251 achieved a 19.7% mean weight loss after 24 weeks in Chinese participants with overweight or obesity, compared to 2.0% for placebo. The trial was conducted by United Biotechnology, a subsidiary of United Laboratories, as part of a licensing agreement where Novo Nordisk acquired global rights to UBT251 in March 2025 for up to $2 billion. Global trial results for UBT251 are expected in 2027, positioning the drug as a potential competitor to existing GLP-1 therapies from Novo Nordisk and Eli Lilly.